One of Cincinnati’s largest public company’s closes on $50M acquisition
June 04, 2019 at 10:34 AM EDT
Meridian Bioscience has completed a cash acquisition of a Canadian provider of molecular diagnostic instruments and assays.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.